FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2167208542> ?p ?o ?g. }

• W2167208542 endingPage "785" @default.
• W2167208542 startingPage "781" @default.
• W2167208542 abstract "Objective: To assess whether pegylated interferon alpha (PEG-IFNα) may induce peripheral neuropathy or antibodies to peripheral nerve antigens in patients with hepatitis C virus (HCV) infection. Methods: We studied 52 patients with HCV (38 men, 14 women; mean age 44.6 ± 10.6 years) treated with IFNα. Before therapy (T), patients underwent quantitative viral RNA determination, HCV genotype analysis, and neurologic and electrophysiologic evaluation. At the end (T1) and after therapy (T2), patients were neurologically and electrophysiologically re-evaluated. Antibodies to gangliosides and sulfatides were assayed by ELISA at T and T1. Twenty-three patients with HCV with comparable age, viral load, and genotype, not treated with IFNα, were studied as controls. Results: Seven patients (six in IFNα, one control) had peripheral neuropathy at recruitment. No significant differences in the electrophysiologic measures were detected between T and T1 (repeated-measures analysis of variance [ANOVA]) in any of the 52 patients or in those with neuropathy at T. No changes were found at T2, independent of the viral response to treatment. Two patients, one with neuropathy, had antiganglioside antibodies at recruitment. Two patients, one not treated with IFNα, developed low antibody titers during follow-up, without symptoms or signs of neuropathy. Conclusions: Pegylated interferon alpha therapy was not associated with the occurrence (or worsening) of peripheral neuropathy or antibodies to peripheral nerve antigens in patients with hepatitis C virus." @default.
• W2167208542 created "2016-06-24" @default.
• W2167208542 creator A5006387483 @default.
• W2167208542 creator A5009411535 @default.
• W2167208542 creator A5011243917 @default.
• W2167208542 creator A5027983945 @default.
• W2167208542 creator A5038006814 @default.
• W2167208542 creator A5047678826 @default.
• W2167208542 creator A5057370615 @default.
• W2167208542 creator A5073634077 @default.
• W2167208542 creator A5079217152 @default.
• W2167208542 creator A5080443886 @default.
• W2167208542 date "2006-09-11" @default.
• W2167208542 modified "2023-10-02" @default.
• W2167208542 title "Peripheral neurotoxicity of pegylated interferon alpha: A prospective study in patients with HCV" @default.
• W2167208542 cites W1976024115 @default.
• W2167208542 cites W1977081412 @default.
• W2167208542 cites W1983318431 @default.
• W2167208542 cites W1983576394 @default.
• W2167208542 cites W2015750559 @default.
• W2167208542 cites W2024227112 @default.
• W2167208542 cites W2024565707 @default.
• W2167208542 cites W2027545702 @default.
• W2167208542 cites W2028856449 @default.
• W2167208542 cites W2061519346 @default.
• W2167208542 cites W2066228803 @default.
• W2167208542 cites W2073024240 @default.
• W2167208542 cites W2073217474 @default.
• W2167208542 cites W2073534729 @default.
• W2167208542 cites W2080071567 @default.
• W2167208542 cites W2081246345 @default.
• W2167208542 cites W2085299945 @default.
• W2167208542 cites W2090025497 @default.
• W2167208542 cites W2095203145 @default.
• W2167208542 cites W2095554023 @default.
• W2167208542 cites W2104701403 @default.
• W2167208542 cites W2115110594 @default.
• W2167208542 cites W2130657245 @default.
• W2167208542 cites W2132937518 @default.
• W2167208542 cites W2140553672 @default.
• W2167208542 cites W2152985701 @default.
• W2167208542 cites W2167117173 @default.
• W2167208542 cites W2168768651 @default.
• W2167208542 cites W2228850141 @default.
• W2167208542 cites W2243291677 @default.
• W2167208542 cites W2317554121 @default.
• W2167208542 cites W2395546240 @default.
• W2167208542 cites W2402365249 @default.
• W2167208542 cites W2470726415 @default.
• W2167208542 cites W34113390 @default.
• W2167208542 cites W92849675 @default.
• W2167208542 doi "https://doi.org/10.1212/01.wnl.0000233889.07772.76" @default.
• W2167208542 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17470762" @default.
• W2167208542 hasPublicationYear "2006" @default.
• W2167208542 type Work @default.
• W2167208542 sameAs 2167208542 @default.
• W2167208542 citedByCount "27" @default.
• W2167208542 countsByYear W21672085422012 @default.
• W2167208542 countsByYear W21672085422014 @default.
• W2167208542 countsByYear W21672085422016 @default.
• W2167208542 countsByYear W21672085422017 @default.
• W2167208542 countsByYear W21672085422020 @default.
• W2167208542 countsByYear W21672085422021 @default.
• W2167208542 crossrefType "journal-article" @default.
• W2167208542 hasAuthorship W2167208542A5006387483 @default.
• W2167208542 hasAuthorship W2167208542A5009411535 @default.
• W2167208542 hasAuthorship W2167208542A5011243917 @default.
• W2167208542 hasAuthorship W2167208542A5027983945 @default.
• W2167208542 hasAuthorship W2167208542A5038006814 @default.
• W2167208542 hasAuthorship W2167208542A5047678826 @default.
• W2167208542 hasAuthorship W2167208542A5057370615 @default.
• W2167208542 hasAuthorship W2167208542A5073634077 @default.
• W2167208542 hasAuthorship W2167208542A5079217152 @default.
• W2167208542 hasAuthorship W2167208542A5080443886 @default.
• W2167208542 hasConcept C126322002 @default.
• W2167208542 hasConcept C134018914 @default.
• W2167208542 hasConcept C159654299 @default.
• W2167208542 hasConcept C203014093 @default.
• W2167208542 hasConcept C2522874641 @default.
• W2167208542 hasConcept C2776178377 @default.
• W2167208542 hasConcept C2776408679 @default.
• W2167208542 hasConcept C2776461080 @default.
• W2167208542 hasConcept C2779901536 @default.
• W2167208542 hasConcept C2780040827 @default.
• W2167208542 hasConcept C2909179924 @default.
• W2167208542 hasConcept C46762472 @default.
• W2167208542 hasConcept C555293320 @default.
• W2167208542 hasConcept C71924100 @default.
• W2167208542 hasConcept C90924648 @default.
• W2167208542 hasConceptScore W2167208542C126322002 @default.
• W2167208542 hasConceptScore W2167208542C134018914 @default.
• W2167208542 hasConceptScore W2167208542C159654299 @default.
• W2167208542 hasConceptScore W2167208542C203014093 @default.
• W2167208542 hasConceptScore W2167208542C2522874641 @default.
• W2167208542 hasConceptScore W2167208542C2776178377 @default.
• W2167208542 hasConceptScore W2167208542C2776408679 @default.
• W2167208542 hasConceptScore W2167208542C2776461080 @default.
• W2167208542 hasConceptScore W2167208542C2779901536 @default.

• next